Tirzepatide Research Peptide UK

Why can’t I order GLP-1 products via the website?

Due to online platform restrictions, GLP-1 compounds cannot be purchased directly through our standard website checkout. All GLP-1 orders are therefore processed manually via WhatsApp, with secure payment arranged through Open Banking. Once confirmed, UK orders are dispatched via Royal Mail Tracked 24, providing a fast and fully tracked delivery service.

Tirzepatide Price UK

Our current Tirzepatide research range:

Tirzepatide 10mg — £65

To order or check current availability, contact Axiom Labs UK via WhatsApp.

Prices and availability may change.

What Is Tirzepatide?

Tirzepatide is a peptide with activity at two important metabolic receptor pathways: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1).

This makes Tirzepatide a dual GIP and GLP-1 receptor agonist, distinguishing it from compounds such as Semaglutide that primarily target the GLP-1 receptor.

The combination of these two incretin pathways has been extensively investigated in metabolic research, particularly in relation to glucose regulation, insulin signalling, appetite, satiety and body-weight regulation.

How Does Tirzepatide Work?

Tirzepatide activates both GIP and GLP-1 receptors.

These are naturally occurring incretin pathways involved in the body's metabolic response to nutrient intake.

GLP-1 Receptor Activity

GLP-1 is a naturally occurring incretin hormone involved in several physiological processes.

Research into GLP-1 receptor signalling has examined its role in:

Glucose-dependent insulin secretion
Appetite signalling
Satiety
Gastric emptying
Glucose regulation
Metabolic function

GLP-1 receptor agonism forms one half of Tirzepatide's dual-receptor mechanism.

GIP Receptor Activity

GIP is another naturally occurring incretin hormone released in response to nutrient intake.

GIP receptor signalling has been investigated in relation to:

Glucose-dependent insulin secretion
Nutrient metabolism
Energy balance
Metabolic regulation

Tirzepatide combines GIP receptor agonism with GLP-1 receptor agonism within a single molecule.

Why Is Tirzepatide Called a Dual-Receptor Agonist?

The term dual-receptor agonist refers to Tirzepatide's activity at two different receptor pathways:

GIP + GLP-1

This differs from several other compounds used within metabolic research:

Semaglutide — GLP-1

Tirzepatide — GLP-1 + GIP

Mazdutide — GLP-1 + Glucagon

Retatrutide — GLP-1 + GIP + Glucagon

Tirzepatide therefore represents an important development from earlier single-receptor GLP-1 compounds and has contributed to increased scientific interest in multi-receptor metabolic research.

Tirzepatide Research

Tirzepatide has been extensively investigated in clinical research involving type 2 diabetes, obesity and body-weight management.

Clinical studies have examined outcomes including:

Body-weight changes
Appetite and satiety
Glycaemic control
HbA1c
Fasting glucose
Insulin sensitivity
Waist circumference
Lipid profiles
Blood pressure
Other cardiometabolic markers

Large clinical research programmes have helped establish the importance of combining GIP and GLP-1 receptor activity within metabolic science.

Tirzepatide and Metabolic Research

One of the most significant areas of modern metabolic research has been the transition from compounds targeting a single incretin receptor towards multi-receptor agonists.

Tirzepatide allows researchers to examine the combined influence of:

GLP-1 receptor signalling

and

GIP receptor signalling

Rather than examining these pathways independently, dual-receptor activity allows their combined metabolic effects to be investigated.

Areas of scientific interest include glucose metabolism, insulin signalling, appetite regulation, energy balance and cardiometabolic health.

Tirzepatide vs Semaglutide

One of the most common comparisons within incretin research is Tirzepatide vs Semaglutide.

The primary difference is their receptor activity.

Semaglutide:
GLP-1 receptor agonist

Tirzepatide:
GIP + GLP-1 receptor agonist

Both involve GLP-1 receptor signalling, but Tirzepatide additionally activates the GIP receptor.

This difference means the two compounds have distinct pharmacological profiles despite sharing GLP-1 receptor activity.

Tirzepatide vs Retatrutide

Tirzepatide and Retatrutide are both multi-receptor compounds but target a different number of metabolic pathways.

Tirzepatide:
GIP + GLP-1

Retatrutide:
GIP + GLP-1 + Glucagon

Retatrutide therefore adds glucagon receptor activity to the GIP and GLP-1 receptor activity also found with Tirzepatide.

This distinction has made dual and triple-receptor agonism important areas of modern metabolic peptide research.

Tirzepatide vs Mazdutide

Tirzepatide and Mazdutide are both dual-receptor agonists, but their receptor profiles differ.

Tirzepatide:
GLP-1 + GIP

Mazdutide:
GLP-1 + Glucagon

Both compounds therefore involve GLP-1 receptor signalling while targeting a different secondary metabolic receptor.

Current Tirzepatide Research

Tirzepatide has progressed substantially beyond early investigational research.

The molecule has been studied through extensive clinical development programmes, providing researchers with significant data surrounding dual GIP and GLP-1 receptor agonism.

Research continues into the broader metabolic and cardiometabolic effects associated with this dual-receptor mechanism.

Frequently Asked Questions About Tirzepatide

What is Tirzepatide?

Tirzepatide is a peptide that acts as a dual GIP and GLP-1 receptor agonist.

Is Tirzepatide a GLP-1?

Tirzepatide has GLP-1 receptor agonist activity, but it is not exclusively a GLP-1 receptor agonist. It also activates the GIP receptor.

How does Tirzepatide differ from Semaglutide?

Semaglutide primarily targets the GLP-1 receptor, while Tirzepatide targets both GLP-1 and GIP receptors.

How does Tirzepatide differ from Retatrutide?

Tirzepatide targets GLP-1 and GIP receptors. Retatrutide targets these same two receptors while additionally targeting the glucagon receptor.

What is Tirzepatide being researched for?

Research involving Tirzepatide has examined areas including glucose regulation, type 2 diabetes, obesity, body-weight regulation and broader cardiometabolic outcomes.

What strength of Tirzepatide does Axiom Labs UK stock?

Our current research range includes:

Tirzepatide 10mg — £65

For current stock availability, please contact Axiom Labs UK directly via WhatsApp.

Tirzepatide Research UK – Axiom Labs

Axiom Labs UK supplies Tirzepatide 10mg for legitimate laboratory, analytical and scientific research applications.

Due to online platform restrictions, Tirzepatide orders are handled exclusively via WhatsApp and cannot be completed through our standard online checkout.

Tirzepatide 10mg — £65

For current availability and research procurement enquiries, please contact Axiom Labs UK via WhatsApp.